ScreenFect GmbH, founded in 2012, is a Germany-based biotechnology company focused on innovation in cell transfection technologies. Its core products, ScreenFect® transfection reagents, are developed using combinatorial chemistry to build unique chemical libraries, followed by high-throughput cellular screening to identify highly efficient formulations. ScreenFect® reagents are suitable for the delivery of various nucleic acids, including pDNA, siRNA, mRNA, and miRNA, supporting both single and co-transfection. They demonstrate strong performance across a wide range of cell types, including hard-to-transfect cells such as primary cells and stem cells.

■ Product Portfolio

Vicbio Biotechnology Co., Ltd. provides the full range of ScreenFect  products.

⇨ Inquire or Order immediately ⇦

1. ScreenFect® A

ScreenFect® A is a versatile transfection reagent suitable for the delivery of pDNA, siRNA, and mRNA, as well as co-transfection applications. It is widely applicable to various cell lines, including HEK, HeLa, MEF, and selected primary cells. High transfection efficiency can be achieved with less than 100 ng DNA in a 96-well plate format.

2.ScreenFect® siRNA

ScreenFect® siRNA is optimized for the delivery of small interfering RNA (siRNA) duplexes. It is suitable for standard mammalian cell lines such as HEK, HeLa, and MEF, as well as a range of primary cell types.

3. ScreenFect® mRNA

ScreenFect® mRNA is a high-efficiency reagent specifically optimized for mRNA transfection, supporting robust expression in various cell systems.

4. ScreenFect® A-plus

ScreenFect® A-plus is an enhanced, multifunctional transfection reagent designed for pDNA, siRNA, and mRNA delivery, including co-transfection applications. It delivers high transfection efficiency across nearly all cell types, including difficult-to-transfect cells.

■ Product List